Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody ; volume:8 ; number:1 ; day:12 ; month:12 ; year:2023 ; pages:1-8 ; date:12.2023
npj vaccines ; 8, Heft 1 (12.12.2023), 1-8, 12.2023
- Creator
-
Inklaar, Maartje R.
Jong, Roos M. de
Bekkering, Ezra T.
Nagaoka, Hikaru
Fennemann, Felix L.
Teelen, Karina
Vegte-Bolmer, Marga van de
Gemert, Geert-Jan van
Stoter, Rianne
King, C. Richter
Proellochs, Nicholas I.
Bousema, Teun
Takashima, Eizo
Tsuboi, Takafumi
Jore, Matthijs M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41541-023-00784-x
- URN
-
urn:nbn:de:101:1-2024022713122585478961
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Inklaar, Maartje R.
- Jong, Roos M. de
- Bekkering, Ezra T.
- Nagaoka, Hikaru
- Fennemann, Felix L.
- Teelen, Karina
- Vegte-Bolmer, Marga van de
- Gemert, Geert-Jan van
- Stoter, Rianne
- King, C. Richter
- Proellochs, Nicholas I.
- Bousema, Teun
- Takashima, Eizo
- Tsuboi, Takafumi
- Jore, Matthijs M.
- SpringerLink (Online service)
Other Objects (12)
Monoclonal enolase-1 blocking antibody ameliorates pulmonary inflammation and fibrosis
Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody
Monoclonal antibody therapy
A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages
A fully human connective tissue growth factor blocking monoclonal antibody ameliorates experimental rheumatoid arthritis through inhibiting angiogenesis
Publisher Correction: A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
Monoclonal antibody applications in travel medicine
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966
Monoclonal enolase-1 blocking antibody ameliorates pulmonary inflammation and fibrosis
Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody
Monoclonal antibody therapy
A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages
A fully human connective tissue growth factor blocking monoclonal antibody ameliorates experimental rheumatoid arthritis through inhibiting angiogenesis
Publisher Correction: A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
Monoclonal antibody applications in travel medicine
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants
Fractional laser ablation for the targeted cutaneous delivery of an anti-CD29 monoclonal antibody – OS2966
Monoclonal enolase-1 blocking antibody ameliorates pulmonary inflammation and fibrosis
Functional Analysis of a Novel Complement C5a Receptor 1-Blocking Monoclonal Antibody
Monoclonal antibody therapy
A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
Potent AMA1-specific human monoclonal antibody against Plasmodium vivax Pre-erythrocytic and Blood Stages
A fully human connective tissue growth factor blocking monoclonal antibody ameliorates experimental rheumatoid arthritis through inhibiting angiogenesis
Publisher Correction: A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders
Monoclonal antibody applications in travel medicine
Mogamulizumab, an anti-CCR4 monoclonal antibody, is a potent therapeutic option for adult T-cell leukemia-lymphoma
Characterisation of a highly potent and near pan-neutralising anti-HIV monoclonal antibody expressed in tobacco plants